Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: (CSE:
$CURA.C) (CSE: $TTT.C) (TSX: $WEED.CA) (NYSE: $CGC) (TSXV: $KHRN.V) (CSE: $CBDT.C)
(CSE: $FFNT.C)
Delta, Kelowna, BC –August 20, 2019 (Investorideas.com
Newswire) www.Investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and
experts.
Listen to the podcast:
Read this in full
at
Good afternoon and welcome to another episode of
Investorideas.com "Potcast" featuring cannabis news, stocks to watch
as well as insights from thought leaders and experts.
In
today’s podcast we look at a few early announcements.
Curaleaf Holdings Inc. (CSE:
CURA) (OTC:
CURLF) launched
its initiative with the Veterans Cannabis Project (VCP), an organization that advocates for
legal and supported access of medical cannabis for veterans through the
Department of Veterans Affairs, in Oregon.
Customers can now purchase a
custom-designed Veterans Cannabis Project pre-roll product, with a portion of
all proceeds benefiting the VCP. Each box includes five pre-rolls (total of 2.5
grams) of UKU flower – one of Oregon's top selling flower brands* – and will be
available for $13. Images can be downloaded here.
"Raising awareness of veterans'
access to cannabis is an important issue for Curaleaf," said Tim
Fitzpatrick, President of Curaleaf Oregon. "Curaleaf can play an important
role by educating veterans and consumers on how cannabis may be of great
benefit for veterans. We are proud to be able to support our veterans as they
look to improve their quality of life."
"As a veteran myself, I was grateful
to be made aware of how medical cannabis can help me," said Doug Distaso,
VCP's Executive Director. "There are millions of veterans, but federal law
makes it illegal for Veteran Health Administration physicians to recommend
cannabis as a treatment. This is something we are looking to change. Our
partnership with Curaleaf will help veterans gain legal access to
cannabis."
Curaleaf officially launched the Veterans
Cannabis Project initiative in Maryland earlier this year; products are
currently available for purchase in Maryland, Maine and Arizona. The company
will continue rolling out the program at Curaleaf dispensaries across the
United States. The Veterans Cannabis Project product will also be available for
purchase at other cannabis operators later this year.
TruTrace
Technologies Inc. (CSE:
TTT) (OTCQB:
TTTSF), creator of the first fully-integrated
blockchain platform that registers and tracks intellectual property for the
cannabis industry, today
announced that it has signed a letter of intent to
establish a strategic working relationship with Anandia Laboratories Inc. The
two companies intend to collaborate on an integrated testing solution in
relation to TruTrace's development of a blockchain-secured traceability
ecosystem for the cannabis industry.
Anandia is considered an industry leader
in science, genetics, and independent cannabis product testing. Pursuant to the
LOI, Anandia will serve as a primary analytical and genetic testing partner in
the TruTrace ecosystem. The parties will also explore ways to work together on
rapidly expediting and optimizing the testing processes under the Cannabis Act
(Canada) as set forth by Health Canada, as well as evolving genetic testing
practices in the cannabis industry.
Anandia is also expected to be one of the
featured testing facilities in the Shoppers Drug Mart and TruTrace Technologies medical cannabis
verification pilot program. As announced by Shoppers at the second annual World
Cannabis Congress, the Pilot Program is built on TruTrace's proprietary
StrainSecure™ platform, which focuses on testing and verification to confirm
the origin, authenticity and quality assurance of cannabis products.
"We are very excited to have Anandia
join us as a testing partner in the StrainSecure ecosystem," said TruTrace
Technologies CEO Robert Galarza. "Its genetic testing expertise and
capabilities combined with its full range of analytical testing makes it a
'one-stop shop' that we expect will play an important role in our traceability
program."
"Establishing a comprehensive
traceability program is an important step for the cannabis industry in offering
full transparency and verification for patients and consumers," said Dr.
John Coleman, Anandia President and Co-Founder. "We are supportive of
these objectives and look forward to working with TruTrace, Shoppers and others
in the Pilot Program."
Under the StrainSecure program, the
TruTrace team collects plant testing data and performs genomic verification in
plant batches which are then registered in a blockchain-enabled database for
intellectual property protection and strain validation. All information
gathered from the plants, including their molecular and chemical makeup, can be
tracked via the program.
Canopy Growth Corporation (TSX:
WEED) (NYSE:
CGC) announced that
it has received a licence from Health Canada for its KeyLeaf
Life Sciences facility
in Saskatoon, Saskatchewan. Including the Smiths Falls site and the recently
licensed BC Tweed extraction site, Canopy Growth now operates three significant
extraction assets to support the throughput required for large scale value-add
product development.
Canopy Growth recently retrofitted the
now fully licensed KeyLeaf facility in Saskatchewan, a company with over 50
years of experience in the extraction industry. This facility is expected to be
online in the Fall of 2019 and has the capacity to extract up to 5,000
kilograms of hemp or cannabis biomass per day. The application for the licence
was submitted under KeyLeaf's previous name, POS Management Corp. and will be
updated in due course. The newly-licensed extraction platform is located in
close proximity to Canopy Growth's large-scale outdoor hemp and cannabis grow
operations. The Company looks forward to the additional capacity increasing
production efficiency, augmenting output volume, and ultimately reducing
operational costs for value-add products set to be rolled out in the Canadian
recreational and medical markets at the end of calendar year 2019.
"With
this milestone, we are executing against the vision of making strategic
investments today in order to deliver results over the long term," said
Mark Zekulin, CEO, Canopy Growth. "This licence will ensure we have the
supply of extraction inputs for the medical, CBD, and recreational markets,
especially the next generation of value-add, high margin cannabis products here
in Canada."
The KeyLeaf facility, and broader
extraction infrastructure that has been recently licensed, will complement the
Company's indoor, greenhouse, and outdoor cannabis and hemp growing operations
on the one side, and its value-add beverages, vapes, softgels and edibles
infrastructure on the other side. The licensing of these facilities brings the
Company one major step closer to completing its Canadian build-out, and also
represents a blueprint model for international expansion as global market
demand dictates.
Khiron Life Sciences Corp. (TSXV:
KHRN) (OTCQB:
KHRNF) announced
today that its shares have received Depository
Trust Company full-service eligibility in the United States. DTC eligibility is
expected to simplify the process of trading and transferring of the Company's
common shares in the United States.
DTC is a subsidiary of the Depository
Trust & Clearing Corp., a U.S. company that manages the electronic clearing
and settlement of publicly traded companies. DTC eligibility permits shares of
Khiron to be distributed, settled and serviced through DTC's automated
processes, leveraging the efficiencies created through the electronic clearing
and settlement of securities. DTC services provide cost benefits for investors
and brokers trading Canadian securities in the United States.
EMPOWER CLINICS INC. (CSE:
CBDT) (OTC:
EPWCF) today
announced that its common shares began trading on
the OTCQB Venture Market at the opening of the market, today on August 20th,
2019 under the stock symbol (OTC: EPWCF).
Empower Clinics Inc. (OTCQB: EPWCF) now
trades on the OTCQB Venture Market for early stage and developing U.S. and
international companies. Companies are current in their reporting and undergo
an annual verification and management certification process. Investors can find
Real-Time quotes and market information for the company on http://www.otcmarkets.com.
In addition, Empower's shares will
continue to be listed on the Canadian Securities Exchange (CSE) under the
ticker symbol "CBDT," as well as on the Frankfurt Stock Exchange
under the ticker symbol "8EC."
"Our listing on the OTCQB Venture
Market in the United States complements Empower's listings on the Canadian and
Frankfurt Stock Exchanges, respectively, broadening our investment base as we
accelerate our growth strategy in the global medical cannabis and wellness
sectors," said Steven McAuley, Empower CEO. "This is a timely milestone, as we have
a robust pipeline of activity tied to product development, business
development, M&A and, overall company expansion."
4Front Ventures Corp. (CSE:
FFNT) (OTCQX:
FFNTF) announced that
it began trading on the OTC Market Group's OTCQX® Best Market under
the new ticker symbol "FFNTF" at market open, today on August 20,
2019.
4Front is a cannabis company designed for
long-term success and built upon battle-tested operating capabilities,
experienced and aligned leadership, a strategic asset base, and a commitment to
being a magnet for talent. From plant genetics to the cannabis retail
experience, 4Front's team can apply expertise across the value chain. 4Front
has invested heavily to assemble a comprehensive collection of management
skills and hands-on operating expertise to capitalize on the unique growth
opportunity being afforded by the increased legalization of cannabis. For more
information, visit 4Front's website.
Investor ideas reminds all listeners to read our disclaimers and
disclosures on the
Investorideas.com website and this podcast is not an endorsement
to buy products or services or securities. Investors are reminded all
investment involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also
available on iTunes, Spotify, Google
Play Music, Stitcher, Spreaker, YouTube
via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark
on the blockchain through Cognate, Inc. CM Certification-Registration Number:
10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news
source publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play
by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News
and Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the AI
Eye Podcast and column covering developments in
AI.
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where
permissible by law. Our site does not possess, distribute, or sell cannabis
products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment